Citation tools
"Timing and Magnitude of Initial Change in Disease Activity Score 28 Predicts the Likelihood of Achieving Low Disease Activity at 1 Year in Rheumatoid Arthritis Patients Treated with Certolizumab Pegol: A Post-hoc Analysis of the RAPID 1 Trial." The Journal of Rheumatology
39.7
(2012):
1326-1333.
Web. 28 Mar. 2024.